TradingView
RocketTickers
11 de Oct. de 2021 17:19
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic process
NYSE:MYOV
1D
Descripción
⋅
11 de Oct. de 2021 17:19
MYOV: Enzyvant
2021-10-09 20:09:51
Enzyvant Receives FDA Approval for RETHYMIC® (allogeneic processed thymus tissue-agdc), a One-Time Regenerative Tissue-Based Therapy for Pediatric Congenital Athymia
Beyond Technical Analysis
Más